Nurix Therapeutics, Inc.NRIXNASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+29.5%
5Y CAGR+36.3%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+29.5%/yr
vs +0.8%/yr prior
5Y CAGR
+36.3%/yr
Recent deceleration
Acceleration
+28.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.7x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$83.98M+54.0%
2024$54.55M-29.1%
2023$76.99M+99.3%
2022$38.63M+29.8%
2021$29.75M+66.9%
2020$17.82M-42.7%
2019$31.11M-16.9%
2018$37.45M-